SBIR/STTR Research Award

Quantitative RT-PCR: Prediction Lymphoma Transformation

Award identifier dd0d3184a7a484121a4f48c8c09cdb4eb1c42efb632ede7ea363aff914baccddAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
IDAHO TECHNOLOGY
Proposal award date
Not reported
Contract end date
Not reported
UEI
NHMDGM122546
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Completion of the human genome and the advent of expression profiling have permitted comprehensive characterization of the transcriptional signatures of different disease states. Quantitative fluorescent real-time polymerase chain reaction-based methods have emerged as a powerful tool in molecular diagnostics as they combine extraordinary dynamic range of quantification and superior specificity. Despite the remarkable advances in real-time fluorescence quantification techniques, this technique has yet to gain widespread application in the analysis of gene expression fixed paraffin-embedded tissues, which is the most common way in which biopsy material is archived. In the R41 phase of this fast-track application, we will establish the utility of a simple approach to the performance of quantitative RT-PCR on RNA derived from formalin-fixed paraffinembedded tissue. The technique is advantageous in that it is simple and compatible with the design of PCR for short amplicons, without compromising target specificity. By the end of the R41 phase of this project, we would have established the feasibility, reproducibility and robustness of our quantitative real-time RT-PCR approach on RNA derived from formalin-fixed paraffin embedded tissue material. These studies will serve as the foundation for the gene expression profiling studies evaluating the predictive power of a previously identified set of ~30 genes to predict the transformation of follicular lymphoma to an aggressive large B-cell lymphoma in phase II.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

26 SBIR/STTR records share this UEI (1999–2013). Reported award amounts total $6,448,942. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.